Previous Article | Next Article ![]()
Journal of Clinical Microbiology, June 1998, p. 1814-1818, Vol. 36, No. 6
Department of Infectious Diseases and Tropical Medicine,
Received 19 December 1997/Returned for modification 13 February
1998/Accepted 20 March 1998
The quality parameters for the detection of microsporidia in
identical sets of 50 stool samples were determined for six laboratories where technicians used light microscopy and for six laboratories where
technicians used PCR. The average overall sensitivities were 67% (89%
for patient samples only) for the PCR laboratories and 54% (80% for
patient samples only) for the light microscopy laboratories.
Specificities were 98 and 95%, respectively. Differences in results
were most apparent between the individual laboratories rather than
between the two major methods used.
In-house evaluations of PCR
protocols, especially by those who developed them, are generally
satisfactory to excellent. In contrast, among the few blinded,
externally controlled evaluations of PCR protocols outside the field of
virology, there have been rather contrasting results. Impressive
examples are the studies by Noordhoek et al. of the detection of
Mycobacterium tuberculosis (17, 18). For
parasites, too, there often exist several PCR protocols for each of the
more frequently and many of the less frequently occurring
human-pathogenic species, including microsporidia (2-6, 8-10,
13-16, 20, 21, 23, 24). However, none of these protocols has
been validated in a blinded, externally controlled fashion. The only
exception is a study by five laboratories of solutions of
Toxoplasma gondii DNA (12). The various results from the different laboratories were attributed to the possible incompatibility of using DNA solutions instead of whole cells with some
of the DNA preparation methods. It was concluded that these artificial
samples were not appropriate for determining the PCR tests'
sensitivities and specificities for clinical specimens.
Hence, while one may recognize the potential of the PCR technique, the
probability of a positive result being correctly positive and a
negative result being from a parasite-free specimen is quite uncertain.
In an effort to assess the performance of this method for the detection
of a parasite, we have conducted a blinded, externally controlled,
multicenter study for the detection of microsporidia by PCR and
compared the results to those obtained by light microscopy. We have
chosen microsporidia (Enterocytozoon bieneusi,
Encephalitozoon intestinalis, Encephalitozoon
hellem, and Encephalitozoon cuniculi), intracellular,
spore-forming parasites responsible for diarrhea and other
manifestations in immunocompromised patients, because the small size of
the spores makes an alternative to their detection by light microscopy
especially advantageous.
Study design.
All technicians from 12 participating
laboratories were informed of and agreed to the following conditions.
Aliquots of 50 stool samples, approximately 1 g each, had to be
analyzed by each laboratory within 3 months. Only stool samples were
tested. Approximately 10 to 30 of the samples were to be negative
controls, most of them originating from healthy, immunocompetent
persons, and the other samples had to be stool samples with confirmed
parasites other than microsporidia. Some positive samples were to be
from healthy persons and spiked with cultured spores of E. intestinalis, E. hellem, or E. cuniculi at
different concentrations. At least one-third of all samples had to be
duplicates, and all samples were assigned a random number. Specimens
were tested by light microscopy at six laboratories (laboratories M1 to
M6), and specimens were tested by PCR at the other six laboratories
(laboratories P1 to P6). The results were to be made public
independently of the outcome, with the participating laboratories
remaining anonymous.
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Blinded, Externally Controlled Multicenter
Evaluation of Light Microscopy and PCR for Detection of
Microsporidia in Stool Specimens
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
20°C until they were divided into aliquots. Spores from Encephalitozoon species (E. cuniculi
IPZ:CH-H14, E. hellem IPZ:CH-H3, and E. intestinalis IPZ:D-H11) were isolated, cultivated on human
embryonic lung fibroblast (MRC-5) cells, characterized both
phenotypically and genotypically as described by Deplazes et al.
(7), and stored at
20°C until used for spiking. Negative stool samples, including those to be spiked, were from immunocompetent, healthy persons without travel histories for the prior 3 months. Four
stool samples were from immunocompetent outpatients suffering from
diarrhea who had confirmed infections with (i) Blastocystis hominis, Endolimax nana, and Entamoeba
hartmanni; (ii) Giardia lamblia only; (iii)
Heterophyes heterophyes only; or (iv) Entamoeba histolytica and B. hominis. Aliquots were prepared,
coded, and distributed by and the results were received at the Robert
Koch Institute in Berlin, Germany, which did not participate in the sample analyses. On the day of the sample preparation, the negative controls were prepared first, the patient samples were next, and the
spiked samples were last. For the spiked samples, the aliquots were
spiked individually. Utmost care was taken to avoid cross-contamination during sample preparation. All samples were shipped without fixatives and at ambient temperature by mail or overseas courier service.
TABLE 1.
Techniques used by light
microscopy laboratoriesa
TABLE 2.
Techniques used by PCR laboratories
Sensitivity. For the six PCR laboratories, the average sensitivity with all samples was 67% (89% for the patient samples only and 44% for the spiked samples only), with a range of 36 to 96%. For the six light microscopy laboratories, the average sensitivity with all samples was 54% (80% for the patient samples only and 27% for the spiked samples only), with a range of 25 to 71%. In this study, differences in sensitivity were more dependent on the individual laboratory than on the analysis method (Table 3). All things considered, technicians at the PCR laboratories achieved, on average, a higher sensitivity (67%) than those at the light microscopy laboratories (54%), scoring 9 percentage points better with the patient samples and 17 percentage points better with the spiked samples. But these averages obscure the wide variations in results between the individual laboratories and must not be taken as the sole argument for favoring one method over the other. For example, 100% sensitivity with the patient samples was attained at five laboratories, three of which were light microscopy laboratories. With samples spiked at the highest concentration, 106 spores/g, technicians from all but one microscopy laboratory detected four or more of the six samples, results which could be matched at only three of the PCR laboratories (Table 4). Light microscopy therefore appears to be the more robust method for high concentrations of spores, while PCR is more sensitive for low concentrations of spores.
|
|
Specificity. Specificity was high at all laboratories, i.e., either 95 or 100%, except at one microscopy laboratory which scored 77% (Table 3). With the exception of this laboratory, no laboratory reported more than one false-positive result, regardless of the method used. This came as a surprise at least for the PCR technique, where cross-contaminations are an imminent danger. In contrast to results of earlier surveys (17, 18), PCR contaminations were infrequent in this study and occurred both in laboratories where single PCRs were performed (P1 and P6) and in one where nested PCRs were performed (P3). Still, more than one such result was never encountered in any laboratory.
Detection limit. A uniform detection limit between 104 and 106 spores per g of stool was apparent for light microscopy only (Table 4). While technicians at two PCR laboratories detected concentrations as low as 102 spores/g, most of the individual results of PCR were varied and increasing spore concentrations did not per se lead to higher sensitivities, except at one laboratory, P1, where all spiked samples were correctly identified but where one sample was also falsely determined to be positive. While samples containing 104 or fewer spores per g could be detected, with a single exception, by PCR only, four or more of the six samples spiked at high concentrations of 106 spores/g were detected by technicians at all but one light microscopy laboratory. Only three PCR laboratories could match this result. Therefore, detection limits were lower but inconsistent by PCR, and light microscopy proved to be the more robust method for detecting high concentrations of spores.
In view of these data, it can be speculated that a substantial number of microsporidial infections currently go undetected, as has been previously suspected for E. intestinalis infections (11), especially with, but not limited to, the moderate-to-low concentrations of spores which might be found in less severely immunocompromised patients. The high sensitivity obtained with the patient samples does not necessarily contradict this explanation, since these samples were screened by light microscopy and are therefore biased towards high concentrations of spores.Genus and species differentiation. Genus determination, which was attempted by technicians at two of the six light microscopy laboratories and at five of the six PCR laboratories, was correctly done in all cases. This finding is therapeutically relevant, because only Encephalitozoon spp. are susceptible to benzimidazole treatment. Morphologically, the spores can be differentiated by size; Enterocytozoon bieneusi spores measure between 1 and 1.5 µm, and Encephalitozoon spp. measure between 2 and 3 µm. The species cannot be distinguished by spore morphology. Technicians at five of the six PCR laboratories differentiated the microsporidia to the species level by analyzing the PCR products and were successful in 87 to 100% of all attempts. Accuracy was highest (89 to 100%) when species-specific primers were used (Table 5). The use of restriction fragment length polymorphism (RFLP) at laboratory P2 was slightly less accurate (87%). However, the percentage of samples correctly identified to the species level by RFLP (71%) was almost identical to the average percentage (73%) from laboratories P1, P3, and P4, where species-specific primers for all four species were used (Table 5).
|
Practical conclusions. The apparent differences in the quality of results between laboratories rather than between the methods employed might be considered an argument for establishing centralized reference centers to guarantee a high level of quality in the detection of microsporidia in stool samples. Until that time, individual laboratories are encouraged to improve their respective techniques as much as possible but not to give up one method in favor of the other. It will certainly be helpful to have a second technique available when a confirmation of the result of the first is desired. While microscopy is known to be highly dependent on the expertise of the examiner, it is not certain if, on the other hand, the generation of a standardized PCR test kit will be a more promising way to guarantee reliable detections of microsporidia by a larger number of laboratories. From the only prior bacteriological study which addressed this question, an unexpected result was that the use of commercial PCR kits did not produce better results than in-house PCR protocols (18). If the reliable detection of microsporidia is not to be restricted to a limited number of reference centers, techniques other than light microscopy and PCR, e.g., coproantigen enzyme-linked immunosorbent assays, might have to be developed.
| |
ACKNOWLEDGMENTS |
|---|
This study would not have been possible without the collaboration and expertise of Cüneyt Acar, Ingrid Blöschl, Christiane Bug, Nico P. Kock, Sabine Köhler, Manuela Reisig, Bärbel Sauer, Justus Schottelius, Slavomir Sproski, Isabelle Tanner, and Ilse Veits.
This study was supported in part by a grant to J. M. Molina from SIDACTION, France.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Infectious Diseases and Tropical Medicine, Leopoldstrasse 5, D-80802 Munich, Germany. Phone: 49-89-21803618. Fax: 49-89-336112. E-mail: rinder{at}lrz.uni-muenchen.de.
Herbert Auer, Felicia David, Bernhard Fleischer, Andreas Haßl,
Walter Heise, Thomas Hoppe, Olivier Liguory, Andreas Müller, Nancy A. Nelson, Otto Picher, Norman J. Pieniazek, and Angelika Thomschke.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Boom, R.,
C. J. Sol,
M. M. Salimans,
C. L. Jansen,
P. M. Wertheim van Dillen, and J. van der Noordaa.
1990.
Rapid and simple method for purification of nucleic acids.
J. Clin. Microbiol.
28:495-503 |
| 2. | Coyle, C. M., M. Wittner, D. P. Kotler, C. Noyer, J. M. Orenstein, H. B. Tanowitz, and L. M. Weiss. 1996. Prevalence of microsporidiosis due to Enterocytozoon bieneusi and Encephalitozoon (Septata) intestinalis among patients with AIDS-related diarrhea: determination by polymerase chain reaction to the microsporidian small-subunit rRNA gene. Clin. Infect. Dis. 23:1002-1006[Medline]. |
| 3. | da Silva, A. J., D. A. Schwartz, G. S. Visvesvara, H. de Moura, S. B. Slemenda, and N. J. Pieniazek. 1996. Sensitive PCR diagnosis of infections by Enterocytozoon bieneusi (microsporidia) using primers based on the region coding for small-subunit rRNA. J. Clin. Microbiol. 34:986-987[Abstract]. |
| 4. | da Silva, A. J., F. J. Bornay-Llinares, C. del Aguila de la Puente, H. Moura, J. M. Peralta, I. Sobottka, D. A. Schwartz, G. S. Visvesvara, S. B. Slemenda, and N. J. Pieniazek. 1997. Diagnosis of Enterocytozoon bieneusi (microsporidia) infections by polymerase chain reaction in stool samples using primers based on the region coding for small-subunit ribosomal RNA. Arch. Pathol. Lab. Med. 121:874-879[Medline]. |
| 5. | da Silva, A. J., S. B. Slemenda, G. S. Visvesvara, D. A. Schwartz, C. M. Wilcox, S. Wallace, and N. J. Pieniazek. 1997. Diagnosis of infections caused by the opportunistic microsporidian Septata intestinalis Cali et al. 1993 using polymerase chain reaction primers targeting the small subunit ribosomal RNA coding region. Mol. Diagn. 2:47-52[Medline]. |
| 6. | David, F., A. R. J. Schuitema, C. Sarfati, O. Liguory, R. A. Hartskeerl, F. Derouin, and J. M. Molina. 1996. Detection and species identification of intestinal microsporidia by polymerase chain reaction in duodenal biopsies from human immunodeficiency virus-infected patients. J. Infect. Dis. 174:874-877[Medline]. |
| 7. | Deplazes, P., A. Mathis, R. Baumgartner, I. Tanner, and R. Weber. 1996. Immunologic and molecular characteristics of Encephalitozoon-like microsporidia isolated from humans and rabbits indicate that Encephalitozoon cuniculi is a zoonotic parasite. Clin. Infect. Dis. 22:557-559[Medline]. |
| 8. | Didier, E. S., L. B. Rogers, A. D. Brush, S. Wong, V. Traina-Dorge, and D. Bertucci. 1996. Diagnosis of disseminated microsporidian Encephalitozoon hellem infection by PCR-Southern analysis and successful treatment with albendazole and fumagillin. J. Clin. Microbiol. 34:947-952[Abstract]. |
| 9. | Fedorko, D. P., N. A. Nelson, and C. P. Cartwright. 1995. Identification of microsporidia in stool specimens by using PCR and restriction endonucleases. J. Clin. Microbiol. 33:1739-1741[Abstract]. |
| 10. | Franzen, C., A. Müller, P. Hegener, P. Hartmann, B. Salzegger, B. Franzen, V. Diehl, and G. Fätkenheuer. 1996. Polymerase chain reaction for microsporidian DNA in gastrointestinal biopsy specimens of HIV-infected patients. AIDS 10:F23-F27[Medline]. |
| 11. | Franzen, C., R. Küppers, A. Müller, B. Salzegger, G. Fätkenheuer, B. Vetten, V. Diehl, and M. Schrappe. 1996. Genetic evidence for latent Septata intestinalis infection in human immunodeficient virus-infected patients with intestinal microsporidiosis. J. Infect. Dis. 173:1038-1040[Medline]. |
| 12. | Guy, E. C., H. Pelloux, M. Lappalainen, H. Aspöck, A. Haßl, K. K. Melby, M. Holberg-Pettersen, E. Petersen, J. Simon, and P. Ambroise-Thomas. 1996. Interlaboratory comparison of polymerase chain reaction for the detection of Toxoplasma gondii DNA added to samples of amniotic fluid. Eur. J. Clin. Microbiol. Infect. Dis. 15:836-839[Medline]. |
| 13. | Katzwinkel-Wladarsch, S., M. Lieb, W. Heise, T. Löscher, and H. Rinder. 1996. Direct amplification and species determination of microsporidian DNA from stool specimens. Trop. Med. Int. Health 1:373-378[Medline]. |
| 14. | Katzwinkel-Wladarsch, S., P. Deplazes, R. Weber, T. Löscher, and H. Rinder. 1997. Comparison of polymerase chain reaction with light microscopy for detection of microsporidia in clinical specimens. Eur. J. Clin. Microbiol. Infect. Dis. 16:7-10[Medline]. |
| 15. | Kock, N. P., H. Petersen, T. Fenner, I. Sobottka, C. Schmetz, P. Deplazes, N. J. Pieniazek, H. Albrecht, and J. Schottelius. 1997. Species specific identification of microsporidia in stool and intestinal biopsy specimens by the polymerase chain reaction. Eur. J. Clin. Microbiol. Infect. Dis. 16:369-376[Medline]. |
| 16. | Liguory, O., F. David, C. Sarfati, A. R. Schuitema, R. A. Hartskeerl, F. Derouin, J. Modai, and J. M. Molina. 1997. Diagnosis of infections caused by Enterocytozoon bieneusi and Encephalitozoon intestinalis using polymerase chain reaction in stool specimens. AIDS 11:723-726[Medline]. |
| 17. |
Noordhoek, G. T.,
A. H. J. Kolk,
G. Bjune,
D. Catty,
J. W. Dale,
P. E. M. Fine,
P. Godfrey-Faussett,
S. N. Cho,
T. Shinnick,
S. B. Svenson,
S. Wilson, and J. D. A. van Embden.
1994.
Sensitivity and specificity of PCR for determination of Mycobacterium tuberculosis: a blind comparison study among seven laboratories.
J. Clin. Microbiol.
32:277-284 |
| 18. | Noordhoek, G. T., J. D. A. van Embden, and A. H. J. Kolk. 1996. Reliability of nucleic acid amplification for detection of Mycobacterium tuberculosis: an international collaborative quality control study among 30 laboratories. J. Clin. Microbiol. 34:2522-2525[Abstract]. |
| 19. | Rinder, H., S. Katzwinkel-Wladarsch, and T. Löscher. 1997. Evidence for the existence of genetically distinct strains of Enterocytozoon bieneusi. Parasitol. Res. 83:670-672[Medline]. |
| 20. | Velásquez, J. N., S. Carnevale, E. A. Guarnera, J. H. Labbé, A. Chertcoff, M. G. Cabrera, and M. I. Rodríguez. 1996. Detection of the microsporidian parasite Enterocytozoon bieneusi in specimens from patients with AIDS by PCR. J. Clin. Microbiol. 34:3230-3232[Abstract]. |
| 21. |
Visvesvara, G. S.,
G. J. Leitch,
A. J. da Silva,
G. P. Croppo,
H. Moura,
S. Wallace,
S. B. Slemenda,
D. A. Schwartz,
D. Moss,
R. T. Bryan, and N. J. Pieniazek.
1994.
Polyclonal and monoclonal antibody and PCR-amplified small-subunit rRNA identification of a microsporidian, Encephalitozoon hellem, isolated from an AIDS patient with disseminated infection.
J. Clin. Microbiol.
32:2760-2768 |
| 22. | Weber, R., R. T. Bryan, R. L. Owen, C. M. Wilcox, L. Gorelkin, G. S. Visvesvara, and the Enteric Opportunistic Infections Working Group. 1992. Improved light-microscopical detection of microsporidia spores in stool and duodenal aspirates. N. Engl. J. Med. 326:161-166[Abstract]. |
| 23. | Weiss, L. M., X. Zhu, A. Cali, H. B. Tanowitz, and M. Wittner. 1994. Utility of microsporidian rRNA in diagnosis and phylogeny: a review. Folia Parasitol. (Ceske Budejovice) 41:81-90. |
| 24. | Zhu, X., M. Wittner, H. B. Tanowitz, D. Kotler, A. Cali, and L. M. Weiss. 1993. Small subunit rRNA sequence of Enterocytozoon bieneusi and its potential role with use of the polymerase chain reaction. J. Infect. Dis. 168:1570-1575[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»